| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/26/2001 | WO2000069415A3 Melt granulation |
| 04/26/2001 | WO2000067787A3 Hiv immunogenic compositions and methods |
| 04/26/2001 | WO2000057869A3 Viral treatment |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | US20010000521 Biological activity inhibiting topoisomerase I and/or topoisomerase II; antitumor agents, viricides |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388859A1 Inhibitors of neuraminidases |
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388427A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | CA2388421A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | CA2388003A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | CA2387896A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387810A1 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | CA2387593A1 Enzyme inhibitors |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387392A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | CA2387348A1 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2386937A1 Iodine containing antimicrobial compositions for mastitis control |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | CA2382985A1 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials |
| 04/25/2001 | EP1094069A1 DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093822A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093821A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen |
| 04/25/2001 | EP1093813A2 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating |
| 04/25/2001 | EP1093812A2 Amoxycillin and clavulanate containing pharmaceutical formulation |
| 04/25/2001 | EP1093517A2 Neisseria meningitidis antigens and compositions |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093382A2 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 04/25/2001 | EP1093366A1 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles |
| 04/25/2001 | EP1093363A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 04/25/2001 | EP1007068A4 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 04/25/2001 | CN1292820A i (Neisseria meningitidis) antigens |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292781A Antivirals |
| 04/25/2001 | CN1292707A Anhydrous topical skin preparation |
| 04/25/2001 | CN1292706A Pneumococcal and meningococcal vaccines formulated with interleukin-12 |
| 04/25/2001 | CN1292697A Anti-viral compound |
| 04/25/2001 | CN1292694A New use |
| 04/25/2001 | CN1292686A Delivery system to modulate immune response |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292378A Trinitrogenazole alcohol antifungal compound and its preparation method |
| 04/25/2001 | CN1292268A Medicine for curing tinea unguium |
| 04/25/2001 | CN1064813C Methylolhydantoins compositions |
| 04/24/2001 | US6222062 Beta-ketoester compounds |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222025 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics |
| 04/24/2001 | US6221959 Polynucleotide, polymer complex |
| 04/24/2001 | US6221903 Amiodarone as an antifungal agent |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221892 Heterocyclic topoisomerase poisons |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221864 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/24/2001 | US6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil |
| 04/24/2001 | US6221847 Administering a bacteriocin produced by dairy propionibacteria |
| 04/24/2001 | US6221844 Texenomycins having a specific amino acid sequence |
| 04/24/2001 | US6221664 Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221365 NucA protein of Haemophilus influenzae |
| 04/24/2001 | US6221363 Vaccine for the prevention of lyme disease |
| 04/24/2001 | US6221362 A vaccine formula allowing the vaccination of avian species, in particular chickens. |
| 04/24/2001 | US6221361 A vector for the delivery of vaccine antigens and therapeutic agents to swine. |
| 04/24/2001 | US6221360 Infectious bovine rhinotracheitis vaccines and methods |
| 04/24/2001 | US6221353 The use of these proteins in vaccines or for the detection of tuberculosis. |
| 04/24/2001 | CA2079172C Cyclohexapeptidyl hydroxypropionitrile compounds |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2021881C Process for preparing lankacidine carbamate derivatives |
| 04/19/2001 | WO2001027330A2 Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027282A1 Plant virus particles with exogenous internal eitopes |
| 04/19/2001 | WO2001027281A1 Designing immunogens |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027271A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027262A1 Gene selection using pnas |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027144A2 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |